Attached files

file filename
EX-32.B - EXHIBIT 32.B - BRISTOL MYERS SQUIBB CObmyex32b_20170331.htm
EX-31.B - EXHIBIT 31.B - BRISTOL MYERS SQUIBB CObmyex31b_20170331.htm
EX-31.A - EXHIBIT 31.A - BRISTOL MYERS SQUIBB CObmyex31a_20170331.htm
EX-12 - COMPUTATION OF EARNINGS TO FIXED CHARGES - BRISTOL MYERS SQUIBB COexhibit12ratioofearningsto.htm
10-Q - FORM 10-Q - BRISTOL MYERS SQUIBB CObmy-20170331x10q.htm


EXHIBIT 32a.
Certification by the Chief Executive Officer Pursuant to 18 U. S. C. Section 1350, as
Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002
Pursuant to 18 U.S.C. Section 1350, I, Giovanni Caforio, hereby certify that, to the best of my knowledge, Bristol-Myers Squibb Company’s Quarterly Report on Form 10-Q for the quarter ended March 31, 2017 (the Report), as filed with the Securities and Exchange Commission on April 27, 2017, fully complies with the requirements of Section 13(a) or Section 15(d) of the Securities Exchange Act of 1934, as amended, and that the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of Bristol-Myers Squibb Company.
 
/s/ Giovanni Caforio
Giovanni Caforio
Chief Executive Officer
April 27, 2017
 


E-32-1